Major chronic diseases-including cardiovascular conditions, diabetes, cancer, and neurodegenerative disorders-remain the leading causes of poor health worldwide. While specific treatments exist, the shared biological roots of these complex conditions are often overlooked. Research typically focuses on single diseases in isolation; however, biological systems are deeply interconnected. For instance, systemic inflammation or metabolic dysfunction can simultaneously elevate the risk for heart disease, cancer, and dementia. To advance patient care, we require a holistic approach that investigates the fundamental molecular machinery governing health and disease across the entire body.
We will leverage the UK Biobank resource to dissect the biological mechanisms underpinning these conditions. By simultaneously analyzing genetic data, circulating proteins (proteomics), metabolic profiles (metabolomics), and multi-modal imaging, we aim to identify convergent pathways. Integrating these distinct data layers allows us to detect “cross-disease” patterns-common molecular drivers that fuel multiple chronic conditions concurrently.
Our primary goal is to discover specific biological markers capable of predicting disease susceptibility, monitoring progression, and estimating treatment response. This knowledge is essential for the shift towards personalized interventions. Rather than applying generalized treatment protocols, our findings aim to empower clinicians to tailor strategies to a patient’s unique biological profile, thereby improving individual outcomes and reducing the overall burden of chronic disease.
